SCHEMBL6897708

SCHEMBL6897708

CC(C)(C)NSCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP1A2 P05177 1/20 0.47
PRMT1 Q99873 1/20 0.47
LMNA P02545 1/20 0.42
SLC6A2 P23975 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
IDO1 P14902 2/20 0.38
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
TP53 P04637 1/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21900951 0.79 PPARG (0.37) LMNACA12CA1CA2CA9
SCHEMBL18723515 0.79 CYP2D6 (0.41) CYP2D6CYP3A4CYP1A2PRMT1LMNA
SCHEMBL28525913 0.78 CYP1A2 (0.38) CYP2D6CYP3A4CYP1A2PRMT1CA12
SCHEMBL18962146 0.75 CYP3A4 (0.46) CYP2D6CYP3A4CYP1A2PRMT1LMNA
SCHEMBL9366877 0.71 TP53 (0.44) CYP2D6CYP3A4CYP1A2PRMT1TAAR1
SCHEMBL30571169 0.71 CYP2D6 (0.48) CYP2D6CYP3A4CYP1A2PRMT1LMNA
SCHEMBL5680420 0.70 CYP2D6 (0.63) CYP2D6CYP3A4CYP1A2PRMT1LMNA
SCHEMBL9577412 0.70 IDO1 (0.41) CYP2D6CYP3A4CYP1A2PRMT1CA12
SCHEMBL8534443 0.70 IDO1 (0.42) CYP2D6CYP3A4CYP1A2PRMT1CA12
Hydrochloric Acid SCHEMBL11149712 0.70 TP53 (0.42) CYP2D6CYP3A4CYP1A2PRMT1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504391-B2 Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders SCHERING CORPORATION (US) 2009-03-17 US disclosed
EP-0845016-B1 STABLE SILANE COMPOSITIONS ON SILICA CARRIER GEN ELECTRIC (US) 2004-07-07 EP disclosed
US-6005027-A ELASTOMER AND BLEND WITH SILANE AND SILICA AND INFRARED ABSORBANCE WITCO CORPORATION (US) 1999-12-21 US disclosed
EP-0845016-A4 STABLE SILANE COMPOSITIONS ON SILICA CARRIER OSI SPECIALTIES INC (US) 1999-04-14 EP disclosed
EP-0845016-A1 STABLE SILANE COMPOSITIONS ON SILICA CARRIER OSi Specialties, Inc. (US) 1998-06-03 EP disclosed
WO-1997007165-A1 STABLE SILANE COMPOSITIONS ON SILICA CARRIER OSI SPECIALTIES, INC. (US) 1997-02-27 WO disclosed